Some centers routinely skip the top kidney transplant candidates on the wait list and give the kidney to lower-ranked patients, finds a new study at Columbia University.
La insuficiencia renal puede tener diversas causas: diabetes, presión arterial alta, enfermedades autoinmunitarias y enfermedad renal poliquística o ERP.
A insuficiência renal pode ser causada por diversos motivos: diabetes, pressão arterial elevada, doenças autoimunes e doença renal policística ou DRP.
قد ينتج الفشل الكلوي عن عدة أسباب منها، السكري وارتفاع ضغط الدم، وأمراض المناعة الذاتية، وداء الكلى متعددة الكيسات.
Cedars-Sinai clinicians and scientists, including Medawar Prize winner Stanley Jordan, MD, and prominent nephrology and immunology investigator Peter Heeger, MD, will share their latest advances in research at the American Transplant Congress (ATC), June 3-7, 2023, in San Diego.
Researchers found that receiving intensive antihypertensive treatment as an inpatient was linked with greater risk of adverse events, particularly for patients receiving the medication intravenously as opposed to orally.
Each year, ASN recognizes individuals who have demonstrated exceptional leadership and achievements in clinical care, education, and research through our lifetime achievement and midcareer awards. Above all, kidney professionals imbue their work with compassion, dedication, and respect for the people whose lives they improve.
The American Society of Nephrology (ASN) announced today that Rajnish Mehrotra, MD, MS, FASN, will be its new Editor-in-Chief of the Journal of the American Society of Nephrology (JASN) and Senior Editor-in-Chief for the ASN Journal Portfolio. Mehrotra’s term will begin January 1, 2024, and continue through December 31, 2029. He currently serves as the Editor-in-Chief of CJASN. The ASN Journal Portfolio includes three monthly journals, JASN, CJASN, and the online-only, open access journal, Kidney360.
Announcement of Zoe Stewart Lewis, MD, PhD, MPH, as the new Director of Cleveland's University Hospitals Transplant Institute and Chief of the Division of Transplant and Hepatobiliary Surgery in the Department of Surgery.
A team of engineers at the University of Colorado Boulder has designed a new class of tiny, self-propelled robots that can zip through liquid at incredible speeds—and may one day even deliver prescription drugs to hard-to-reach places inside the human body.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Unfortunately, effective medical therapies do not exist for this population of patients, Dr. Pavan Bhatraju said. In their paper, the investigators proposed a way to classify subpopulations of AKI patients with the aim of identifying therapies specific patient populations.
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology’s annual meeting.
The American Society of Nephrology (ASN) applauds the introduction of the Securing the U.S. Organ Procurement and Transplantation Network Act (S. 1668), bipartisan legislation to ensure accountability and transparency in the U.S. transplant system by modernizing its underlying technology and policy infrastructure.
The number of deaths worldwide from ischemic stroke increased from 2 million in 1990 to more than 3 million in 2019, and is expected to increase to nearly 5 million by 2030, according to a study published in the May 17, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study focused on ischemic stroke, which is caused by a blockage of blood flow to the brain and is the most common type of stroke.
Giving people at high risk of PFAS exposure the opportunity to easily self-test could improve access to testing for these “forever chemicals” and lead to the early detection of detrimental health conditions, according to a new Michigan State University study. The study tested an improved approach for people to collect their own blood samples to test for PFAS without being part of an academic research study.
The Wake Forest Institute for Regenerative Medicine (WFIRM) will make history this month when the first bioprinted solid tissue constructs soar to the International Space Station (ISS) on board the next all private astronaut mission by commercial space leader Axiom Space.
Researchers from Sanford Burnham Prebys and the Chinese University of Hong Kong have developed a computational approach to predict whether a person with type 2 diabetes will develop kidney disease. The findings could help doctors prevent or better manage kidney disease in people with type 2 diabetes.
It's one thing to buy your mother flowers or a gift certificate to the spa for Mother’s Day - but it’s a whole other thing to give her the gift of life. In a reversal of roles, thanks to the miracle of kidney donation, a New Jersey daughter was able to give her own mother the gift of life, 37 years after her mom gave her life.
Hackensack Meridian Hackensack University Medical Center’s Department of Urology presented 14 abstracts at the American Urological Association’s (AUA) 2023 Annual Meeting.
A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research published in The New England Journal of Medicine and led by an oncologist from Dana-Farber Cancer Institute.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
In medicine and science, the term “pathogenesis” describes the origin and development of disease. There is not, however, a broadly accepted term to describe the other half of the equation: the process of healing and recovery.
For patients with kidney stones measuring one to two centimeters, a technique called mini-percutaneous nephrolithotomy (mini-PCNL) provides a higher stone elimination rate than another minimally invasive procedure called ureteroscopy (URS), concludes a randomized trial in the June issue of The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Acute kidney injury (AKI) represents a major morbidity following cardiac surgery; and, when moderate or severe, it is strongly associated with postoperative mortality. Approximately one-third of adults and up to half of all children who undergo cardiac surgery develop some degree of postoperative AKI.
Sian Piret, PhD, in the Renaissance School of Medicine at Stony Brook University, has received a $1.4 million grant from the National Institute of Health’s National Institute of Diabetes and Digestive and Kidney Diseases to investigate a certain metabolic process called BCAA catabolism that is known to occur with acute kidney injury, but its exact role remains unknown.
Upon an arrival to the emergency department for abdominal pain of unknown cause, most non-pregnant adult patients receive a CT scan with IV contrast to diagnose the source of the pain. However, IV contrast can be a risk in patients with severe kidney disease or at risk for an allergic reaction from the dye. When scans are performed without IV contrast, though, they are usually less accurate, which can lead to misdiagnosis.
For millions of Americans that suffer from seasonal allergies (pollen and mold), climate change is exacerbating an earlier, longer, and overall worse allergy season.
Researchers at Children’s Hospital Los Angeles have now pinpointed a disruption in early kidney progenitor cell development that can be linked to the formation of Wilms tumor.
• The Living Donor Protection Act (LDPA) will remove barriers facing living donors. • Approximately 90,000 adults and 1,100 children are on the kidney transplant waitlist. • 12 American die every day while waiting for a kidney transplant. • More than 37 million Americans are living with kidney diseases, including more than 800,000 with kidney failure.
Experts from the Cedars-Sinai Comprehensive Transplant Center and Smidt Heart Institute are available for interviews about transplantation, immunology and organ donation in April, Donate Life Month, and throughout the year.
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center and the Department of Urology at the David Geffen School of Medicine at UCLA will be joining thousands of urology experts on April 28 to May 1 for the American Urological Association (AUA) Annual Meeting.
Hackensack University Medical Center is the first hospital in the country to invest in the new LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System, and one of the first U.S. hospitals to use this next-generation system, which has the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures.
Little is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors. But a study out of Roswell Park Comprehensive Cancer Center is shedding light on that process, providing information that could be key for planning treatment regimens that combine immunotherapy and radiation therapy. The authors outline their findings in a new study in the Journal for ImmunoTherapy of Cancer.
In a study conducted at Hospital for Special Surgery (HSS), researchers found that the use of peripheral nerve blocks in total knee and total hip arthroplasty were associated with a consistent reduction in risk for postoperative complications in patients with a lower comorbidity burden. In particular, the most consistent reduction in risk of complications and use of hospital resources was in older patients with no comorbidity burden. These findings were presented at the 2023 Spring American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Meeting and were acknowledged as one of the President’s Choice Abstracts.1
Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.
New research results suggest that the widely used diabetes drug metformin may be beneficial for recovering from short periods of severe food insecurity or anorexia.
MaryAshley Barbot waited 10 years for a new kidney, but the hospitals near her South Carolina home were unable to find a match. Now, the teenager is in the best health of her life, six months after receiving a kidney transplant at Cedars-Sinai.
Members of the House of Representatives Committee on Energy and Commerce signaled support for the Securing the U.S. Organ Procurement and Transplantation Network Act (SUS OPTN) during the Energy and Commerce Health Subcommittee Hearing on Existing Healthcare Workforce and Primary Care Programs.
Vijay Goradia, a Houston-based businessman, philanthropist, and cancer survivor, has donated $10 million to The University of Texas MD Anderson Cancer Center to speed translational research and clinical trials.
Since the Spanish Language Clinic began in April 2022, more than 160 patients have signed up with the clinic, which specifically treats Spanish-speaking patients on Tuesdays and Fridays, said Samantha Mok, transplant outreach coordinator at UI Health.
In a new study, researchers from The University of Texas MD Anderson Cancer Center created the largest single-cell atlas of brain metastases from renal cell carcinoma (RCC) with matched primary and extracranial metastases, enabling the discovery of key biological mechanisms driving an immunosuppressive tumor microenvironment in the brain distinct from that of the kidney or other metastatic sites.
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and disease control rates in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to results of a Phase I trial led by researchers at The University of Texas MD Anderson Cancer Center and presented today at the American Association for Cancer Research (AACR) Annual Meeting 2023.
A new Japanese study reveals significant birth cohort effects on the incidence trend of ESKD requiring RRT.
The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce four winners for the 2023 NCCN Foundation Young Investigator Awards. These annual awards honor up-and-coming leaders in oncology research working to investigate and advance cancer care.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
